Results 181 to 190 of about 217,258 (295)

P660: NEXT-GENERATION SEQUENCING (NGS) FOR DETECTING BCR::ABL-INDEPENDENT MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WITH RESISTANCE TO TYROSINE KINASE INHIBITOR TREATMENT

open access: gold, 2023
Daria Kustova   +7 more
openalex   +1 more source

A Patient‐Derived Organoid Biobank of Adamantinomatous Craniopharyngioma as a Platform for Drug Discovery

open access: yesAdvanced Science, Volume 13, Issue 7, 3 February 2026.
This study successfully establishes adamantinomatous craniopharyngioma (ACP) patient‐derived organoids (PDOs) that preserve the histopathological and genetic features of the original tumors. Through drug sensitivity assays and subsequent mechanistic analyses, the study demonstrates that Ceritinib exerts its inhibitory effects on ACP PDO growth by ...
Huarong Zhang   +15 more
wiley   +1 more source

Sharp commutator estimates of all order for Coulomb and Riesz modulated energies

open access: yesCommunications on Pure and Applied Mathematics, Volume 79, Issue 2, Page 207-292, February 2026.
Abstract We prove functional inequalities in any dimension controlling the iterated derivatives along a transport of the Coulomb or super‐Coulomb Riesz modulated energy in terms of the modulated energy itself. This modulated energy was introduced by the second author and collaborators in the study of mean‐field limits and statistical mechanics of ...
Matthew Rosenzweig, Sylvia Serfaty
wiley   +1 more source

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 2, February 2026.
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch   +9 more
wiley   +1 more source

The Application of Iron Nanoparticles Green‐Synthesized by Coptis chinensis Leaf Aqueous Extract in Reducing the TNF‐α and IL1‐β Inflammatory Cytokines in the Rat Periodontal Model

open access: yesFood Science &Nutrition, Volume 14, Issue 2, February 2026.
Treatment of periodontitis by the iron nanoparticles. ABSTRACT The study purpose was to examine how the green‐synthesized iron nanoparticles (FeNPs) made from Coptis chinensis extract affected the TNF‐α and IL1‐β gingival levels in the rat periodontal model. The extract from C. chinensis was utilized as a green reducing agent and a great stabilizer for
Jialing Wu, Xinjie Gao, Ruiqi Li
wiley   +1 more source

Home - About - Disclaimer - Privacy